CrossrefInfokarte
Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Colorectal Cancer: Results From the Phase II LEAP-005 Study
Clinical Colorectal Cancer · 2026-06 · 25 (2) · 225-238.e2
DOI: 10.1016/j.clcc.2026.01.003 ↗Abstract
Kein Abstract verfügbar.
EUVIMED